DiaMedica Therapeutics Inc.
Income Statement
| Line Item | FY2018 |
|---|---|
| Revenue | $500.0K |
| Cost of Revenue | — |
| Gross Profit | — |
| Gross Margin | — |
| Operating Expenses | |
| Research & Development | $4.5M |
| SG&A Expense | $2.7M |
| Operating Income | $-6.8M |
| Operating Margin | -1,352.2% |
| Interest Expense | — |
| Pretax Income | $-5.7M |
| Income Tax Expense | $80.0K |
| Net Income | $-5.7M |
| Net Margin | -1,146.8% |
| EPS (Basic) | $-0.74 |
| EPS (Diluted) | $-0.74 |
| Shares Outstanding (Basic) | 12.0M |
| Shares Outstanding (Diluted) | 12.0M |
| Dividends Per Share | — |